nVerses Capital’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

nVerses Capital’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,300	Closed	-$78.4K	–	1445
2024 Q2	$78.4K	Buy	2,300 +1,200	+109%	+$35.5K	0.05%	490
2024 Q1	$38.7K	Buy	+1,100	New	+$36.9K	0.09%	317

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

nVerses Capital's MORF Position: Q3 2024 in Review

nVerses Capital sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 2,300 shares — an estimated $78.4K sold.

nVerses Capital first reported a position in MORF in Q1 2024 and held it in 2 quarters. The position peaked at $78.4K in Q2 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

nVerses Capital reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 2,300 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $78.4K.
nVerses Capital first reported a position in Morphic Holding, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
nVerses Capital's Morphic Holding, Inc. Common Stock position peaked at $78.4K in Q2 2024.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.